Samsung is stepping deeper into the healthcare game, this time with a dedication to far more than just counting steps or monitoring sleep. The company announced today that it has signed an agreement to acquire Xealth, a healthcare integration platform already entrenched in over 500 US hospitals. It’s a bold move, and one aimed squarely at transforming compact wearables into a seamless conduit between wellness tracking and real medical care.
Connecting consumers with carers
And enabling comprehensive coverage
If you haven’t heard of Xealth, here are the basics: it’s a spin-off of the Providence health system and has since built a platform combining data from over 70 digital health tools into a single interface. In other words, healthcare providers will see real-time insight into patient data, making continuous engagement and smarter clinical decisions easier, especially for those managing chronic conditions or home recovery.
Samsung’s endgame is clear: bridge the growing gap between everyday wellness monitoring and hospital-grade healthcare — all without asking users to juggle multiple apps, devices, or platforms. By upgrading its ecosystem with Xealth’s wealth of wellness connections, Samsung aims to be more than just your favorite wearable brand. It wants to be the company taking care of your health.
That goal steps up the competition with alternatives like the Oura Ring, which has seen rapid adoption thanks to sleek design and deep insights based on consumer-driven metrics. Samsung is looking to go further by integrating wearables directly into clinical decision-making, instead of just personal lifestyle tweaks.
This also dovetails with Samsung’s recently announced partnership with Dexcom, the maker of continuous glucose monitors used by people with diabetes. The Samsung Health suite already supports Dexcom G7 GCM data on Galaxy Watches, and Xealth’s integrations could greatly enhance its effectiveness by helping clinicians see how glucose levels, sleep, exercise, and other biometrics interact in the real world. It’s the kind of closed-loop system that the healthcare industry has talked about for years, and Samsung looks ready to deliver.
TM Roh, President and Acting Head of Samsung’s DX division, framed the move as “an anchor” to support digital health partners and healthcare systems alike. Xealth’s CEO Mike McSherry echoed that sentiment, highlighting how data from wearables can now offer hospitals missing context and richer analysis.
The deal is expected to close sometime in 2025, pending regulatory approvals. If all goes as planned, Samsung could soon be the brand not just on your wrist — but in your medical chart, too.
